|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 477.08 USD | +0.16% |
|
-8.65% | +5.23% |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
 | 556.96 | +16.93% | 25 | ||||||
| 1,255.86 | +8.96% | 28 | ||||||
| 262.27 | +3.32% | 22 | ||||||
| 265.5 | +8.46% | 28 | ||||||
| 359.22 | +9.85% | 18 | ||||||
| 153.3 | +1.17% | 21 | ||||||
| 212.84 | +28.49% | 22 | ||||||
| 316.91 | -0.87% | 24 | ||||||
| 356.62 | +0.39% | 29 | ||||||
| 158.3 | +21.73% | 27 | ||||||
| 28.79 | +18.71% | 26 | ||||||
| 62.96 | +10.55% | 24 | ||||||
| 96.31 | +27.57% | 23 | ||||||
| 21.2 | +10.39% | 19 | ||||||
| 9,860 | +36.17% | 15 | ||||||
| 54.92 | +11.8% | 18 | ||||||
| 80.52 | +46.88% | 15 | ||||||
| 6,106.87 | +14.64% | 15 | ||||||
| 4.142 | +14.97% | 17 | ||||||
| 435.33 | +54.78% | 24 | ||||||
| Average | 1,032.44 | +17.24% | 22 | ||||||
| Weighted average by Cap. | 705.28 | +10.96% | 24 |
- Stock Market
- Stocks
- VRTX Stock
- Sector Vertex Pharmaceuticals Incorporated
- Sector consensus
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
